SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - FRA:SNW - FR0000120578 - Common Stock
85.94 EUR
-1.68 (-1.92%)
We assign a fundamental rating of 6 out of 10 to SNW. SNW was compared to 54 industry peers in the Pharmaceuticals industry. While SNW has a great profitability rating, there are some minor concerns on its financial health. SNW is not valued too expensively and it also shows a decent growth rate. SNW also has an excellent dividend rating. With these ratings, SNW could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
SNW had positive earnings in the past year.
SNW had a positive operating cash flow in the past year.
SNW had positive earnings in each of the past 5 years.
Each year in the past 5 years SNW had a positive operating cash flow.
1.2 Ratios
SNW has a Return On Assets of 11.05%. This is in the better half of the industry: SNW outperforms 77.78% of its industry peers.
Looking at the Return On Equity, with a value of 19.73%, SNW is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.84%, SNW is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
SNW had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 14.51%.
The 3 year average ROIC (7.31%) for SNW is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
With a decent Profit Margin value of 20.35%, SNW is doing good in the industry, outperforming 79.63% of the companies in the same industry.
SNW's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 23.59%, SNW is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
In the last couple of years the Operating Margin of SNW has grown nicely.
SNW has a Gross Margin of 71.70%. This is comparable to the rest of the industry: SNW outperforms 55.56% of its industry peers.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SNW is creating some value.
SNW has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for SNW remains at a similar level compared to 5 years ago.
SNW has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of SNW is 2.21, which is a good value as it means it would take SNW, 2.21 years of fcf income to pay off all of its debts.
SNW's Debt to FCF ratio of 2.21 is amongst the best of the industry. SNW outperforms 83.33% of its industry peers.
SNW has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SNW has a Debt to Equity ratio of 0.21. This is in the better half of the industry: SNW outperforms 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.8
WACC7.71%
2.3 Liquidity
A Current Ratio of 1.27 indicates that SNW should not have too much problems paying its short term obligations.
SNW has a Current ratio of 1.27. This is comparable to the rest of the industry: SNW outperforms 44.44% of its industry peers.
A Quick Ratio of 0.94 indicates that SNW may have some problems paying its short term obligations.
SNW has a Quick ratio (0.94) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -5.35% in the last year.
SNW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
The Revenue has been growing slightly by 2.56% in the past year.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
Based on estimates for the next years, SNW will show a small growth in Earnings Per Share. The EPS will grow by 7.06% on average per year.
SNW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.52% yearly.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.31, which indicates a very decent valuation of SNW.
Based on the Price/Earnings ratio, SNW is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.47. SNW is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.01, the valuation of SNW can be described as very reasonable.
Based on the Price/Forward Earnings ratio, SNW is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
SNW's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.31 | ||
| Fwd PE | 10.01 |
4.2 Price Multiples
61.11% of the companies in the same industry are more expensive than SNW, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 62.96% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.79 | ||
| EV/EBITDA | 11.03 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of SNW may justify a higher PE ratio.
PEG (NY)3.69
PEG (5Y)2.22
EPS Next 2Y5.75%
EPS Next 3Y6.01%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.33%, SNW is a good candidate for dividend investing.
SNW's Dividend Yield is rather good when compared to the industry average which is at 3.01. SNW pays more dividend than 85.19% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, SNW pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.33% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
34.82% of the earnings are spent on dividend by SNW. This is a low number and sustainable payout ratio.
SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
FRA:SNW (11/19/2025, 7:00:00 PM)
85.94
-1.68 (-1.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap209.35B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target106.41 (23.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.33% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-2.88%
PT rev (3m)-2.13%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-6.91%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-4.9%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.31 | ||
| Fwd PE | 10.01 | ||
| P/S | 3.08 | ||
| P/FCF | 20.79 | ||
| P/OCF | 18.4 | ||
| P/B | 2.99 | ||
| P/tB | 22.53 | ||
| EV/EBITDA | 11.03 |
EPS(TTM)7.6
EY8.84%
EPS(NY)8.59
Fwd EY9.99%
FCF(TTM)4.13
FCFY4.81%
OCF(TTM)4.67
OCFY5.44%
SpS27.87
BVpS28.74
TBVpS3.82
PEG (NY)3.69
PEG (5Y)2.22
Graham Number70.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.71%
ROIC/WACC1.8
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SNW.DE FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SNW.DE) has a profitability rating of 7 / 10.
What is the financial health of SANOFI (SNW.DE) stock?
The financial health rating of SANOFI (SNW.DE) is 5 / 10.
What is the expected EPS growth for SANOFI (SNW.DE) stock?
The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 3.07% in the next year.